Use of antibiotics in upper respiratory infections on patients under 16 years old in private ambulatory medicine
Salud pública Méx
;
45(3): 159-164, mayo-jun. 2003. tab
Artigo
em Inglês
| LILACS
| ID: lil-349870
ABSTRACT
OBJECTIVE:
To assess antibiotic use for upper respiratory infections (URI) treatment on patients under 16 years-old who are beneficiaries of a pre-paid health care scheme. MATERIAL ANDMETHODS:
A database containing the record of all the medical prescriptions for URI treatment, from May 1997 to April 1998 was analyzed. Patients were under 16 years old and had been diagnosed with common colds, pharyngitis, bronchitis, sinusitis, otitis, and other unspecified upper respiratory tract infections. Three hundred and fifty-one physicians of seven different specialties who attended 25 300 beneficiaries wrote such prescriptions.RESULTS:
A total of 30 889 assorted medications were prescribed to 5 533 patients with the above diagnoses. Antibiotics were prescribed for 77.5 percent of all diagnoses, ranging from 58 percent for pharyngitis to 91 percent for laryngitis. The most frequently used antibiotics were penicillin, cephalosporins, and macrolides.CONCLUSIONS:
This study presents the information of antibiotics prescription practices for URI in a pre-paid health plan in Mexico. These findings may be used to support specific campaigns for rational use of antibiotics among children attended at private ambulatory health care practices
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Prática Privada
/
Infecções Respiratórias
/
Planos de Pré-Pagamento em Saúde
/
Assistência Ambulatorial
/
Antibacterianos
Tipo de estudo:
Estudo observacional
Limite:
Adolescente
/
Criança
/
Criança, pré-escolar
/
Humanos
/
Lactente
País/Região como assunto:
México
Idioma:
Inglês
Revista:
Salud pública Méx
Assunto da revista:
Saúde Pública
Ano de publicação:
2003
Tipo de documento:
Artigo
País de afiliação:
México
Instituição/País de afiliação:
Hospital General de México/MX
/
Instituto Nacional de Pediatría/MX
/
Merck Sharp & Dohme de México/MX
Similares
MEDLINE
...
LILACS
LIS